DK0640618T3 - Tetrahydronaphthalen-peptidderivater - Google Patents

Tetrahydronaphthalen-peptidderivater

Info

Publication number
DK0640618T3
DK0640618T3 DK94112544T DK94112544T DK0640618T3 DK 0640618 T3 DK0640618 T3 DK 0640618T3 DK 94112544 T DK94112544 T DK 94112544T DK 94112544 T DK94112544 T DK 94112544T DK 0640618 T3 DK0640618 T3 DK 0640618T3
Authority
DK
Denmark
Prior art keywords
image
configuration
amino acid
alpha
present
Prior art date
Application number
DK94112544T
Other languages
English (en)
Inventor
Christine Abrecht
Klaus Mueller
Daniel Obrecht
Arnold Trzeciak
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0640618T3 publication Critical patent/DK0640618T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94112544T 1993-08-27 1994-08-11 Tetrahydronaphthalen-peptidderivater DK0640618T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH255293 1993-08-27

Publications (1)

Publication Number Publication Date
DK0640618T3 true DK0640618T3 (da) 2000-04-03

Family

ID=4236370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94112544T DK0640618T3 (da) 1993-08-27 1994-08-11 Tetrahydronaphthalen-peptidderivater

Country Status (7)

Country Link
US (1) US5644024A (da)
EP (1) EP0640618B1 (da)
JP (1) JPH0789987A (da)
AT (1) ATE185813T1 (da)
DE (1) DE59408838D1 (da)
DK (1) DK0640618T3 (da)
ES (1) ES2138639T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0729972A1 (de) * 1995-02-28 1996-09-04 F. Hoffmann-La Roche Ag Tetrahydronaphthalin-Peptidderivate
GB9509156D0 (en) 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
WO2003004149A1 (fr) * 2001-07-06 2003-01-16 Daicel Chemical Industries, Ltd. Agent de separation d'isomere optique et procede de preparation de cet agent
ES2739433T3 (es) 2013-09-09 2020-01-31 Peloton Therapeutics Inc Aril éteres y usos de los mismos
WO2016144825A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
EP3267792A4 (en) 2015-03-11 2018-09-26 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
EP3268362B1 (en) 2015-03-11 2021-10-20 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10335388B2 (en) 2015-04-17 2019-07-02 Peloton Therapeutics, Inc. Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2101599A1 (en) * 1992-08-31 1994-03-01 Wilhelm Bannwarth Tri- and tetracyclic compounds

Also Published As

Publication number Publication date
EP0640618A1 (de) 1995-03-01
ATE185813T1 (de) 1999-11-15
DE59408838D1 (de) 1999-11-25
US5644024A (en) 1997-07-01
EP0640618B1 (de) 1999-10-20
JPH0789987A (ja) 1995-04-04
ES2138639T3 (es) 2000-01-16

Similar Documents

Publication Publication Date Title
HUP0003921A2 (hu) VLA-4 által közvetített leukocitaadhéziót gátló szulfonilezett dipeptidszármazékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0301249A2 (hu) APO B termelődés gátló benzamid-vegyületek ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69315079T2 (de) Beta-aminoalkyl und beta-n-peptidylaminoalkylborsäure
DE69114117D1 (de) Neue Verwendung von Peptidderivat.
DK0640618T3 (da) Tetrahydronaphthalen-peptidderivater
FI906296A (fi) Nya metylenbisfosfonsyrederivat.
ES2118909T3 (es) Material foto-reactivo.
DK640889D0 (da) Fenylderivater med antidiabetisk, isaer hypoglykaemisk virkning
CO5160241A1 (es) 2-aminopiridinas que contienen sustituyentes de tipo anillo condensado
IE894039L (en) Therapeutic agents
DE69224613T2 (de) Peptide, Herstellung und deren Verwendung
GB9225348D0 (en) Bridged photochromics
HUP0000490A2 (hu) Ciklopeptidszármazékok
DE69427394D1 (de) Kondensierte heterocyclische glutaminsäurederivate als antiproliferative mittel
CO5130024A1 (es) Derivados de azabicicloheptano n-sustituidos. .
ES2112470T3 (es) Derivados de piridazinona, procedimientos de produccion y utilizacion.
CO4990935A1 (es) Derivados de tiazol
FI933118A (fi) Oksodibentsoksepiinijohdannaiset
JO1633B1 (en) Therapeutic agents